Blood product utilization and management in Canada

Area of Science:

• Transfusion Medicine
• Hematology
• Public Health

Background:

• Blood transfusion utilization in Canada has been consistent over the last six years, ranging between 900,000-950,000 units annually.
• Blood donation rates have seen a slight decrease from a 1989 peak of 1,200,000 units per annum.
• Significant shifts in blood component utilization are evident, including decreased use of fresh plasma and cryoprecipitate.

Purpose of the Study:

• To analyze trends in blood utilization and donation in Canada over a six-year period.
• To identify changes in the usage patterns of specific blood components.
• To evaluate the impact of specialized training on transfusion practices.

Main Methods:

• Retrospective analysis of national blood utilization data.
• Tracking of blood donation volumes over time.
• Comparison of blood component usage statistics.
• Assessment of a compulsory transfusion medicine rotation for anesthesia residents in Vancouver.

Main Results:

• Blood transfusion volumes remained stable, while donation rates slightly declined.
• Platelet usage has doubled, and albumin use has increased without clear explanation.
• Fresh plasma and cryoprecipitate utilization has decreased.
• A compulsory transfusion medicine rotation in Vancouver appears to rationalize transfusion practices.

Conclusions:

• Canadian blood transfusion services face a stable demand but declining donations.
• Shifting component use, particularly increased platelet and albumin demand, requires further investigation.
• Educational interventions, like transfusion medicine rotations, show promise in optimizing transfusion practices.